Drug Database
EP

epinastine (Talerc / Flurinol / Alesion Dry Syrup)

✓ Approved

Daiichi Sankyo Company Limited · HRH1 · 小分子

什么是 epinastine?

epinastine 是一种小分子,由Daiichi Sankyo Company Limited研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名Talerc, Flurinol, Alesion Dry Syrup
公司Daiichi Sankyo Company Limited
药物类别小分子
分子靶点HRH1
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

epinastine 作用于 1 个分子靶点:

HRH1histamine receptor H1 (HH1R, H1R)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

epinastine 针对 4 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Respiratory, thoracic and mediastinal disordersAsthma✓ Approved
Skin and subcutaneous tissue disordersDermatitis allergic✓ Approved
Skin and subcutaneous tissue disordersDermatitis atopic✓ Approved
Respiratory, thoracic and mediastinal disordersRhinitis allergic✓ Approved

相关研究文献

PubMedFrontiers in pharmacology2026-11-17

Comparative efficacy and safety of topical olopatadine formulations for allergic conjunctivitis: a systematic review and network meta-analysis.

Li Caiju C, Gao Yuying Y, Wei Lijuan L

Allergic conjunctivitis (AC) affects 15%-40% of the global population. Traditional network meta-analyses often group different formulations of olopatadine into a single node, obscuring concentration-dependent variations. This network meta-analysis evaluated the relative efficacy and safety of distinct olopatadine concentrations (0.1%, 0.2%, 0.77%) against other topical anti-allergic or anti-inflammatory agents. Registered in PROSPERO (CRD420261375330), this study systematically searched major databases up to 1 May 2026, for randomized controlled trials (RCTs) on adults with AC. Interventions evaluated olopatadine formulations (0.1% BID, 0.2% QD, 0.77% QD) as independent nodes alongside 0.05% epinastine, 0.025% ketotifen, 0.25% alcaftadine, 1.5% bepotastine, 0.2% loteprednol etabonate, or placebo. Frequentist random-effects network meta-analyses were performed. Nineteen randomized controlled trials (RCTs) encompassing 2,745 patients (5,141 eyes) were analyzed. For ocular itching (18 RCTs), 0.77% olopatadine demonstrated superior efficacy among dual-acting agents (SUCRA = 80.7%), significantly outperforming epinastine and ketotifen. For conjunctival hyperemia (17 RCTs), 0.25% alcaftadine demonstrated the highest likelihood of efficacy (SUCRA = 66.5%), whereas among olopatadine formulations, only 0.2% significantly outperformed placebo (SUCRA = 47.4%). Subgroup analyses showed that 0.77% olopatadine and 0.25% alcaftadine were particularly effective against acute itching in conjunctival allergen challenge models. Safety assessments across 11 RCTs yielded wide confidence intervals due to data sparsity, precluding definitive tolerability rankings. Although trial data predominantly reported mild adverse events, external evidence highlights key long-term safety concerns, notably intraocular pressure elevation associated with extended topical corticosteroid therapy such as 0.2% loteprednol etabonate. Topical dual-acting agents demonstrate outcome-specific efficacy variations in allergic conjunctivitis management. Olopatadine 0.77% excels in pruritus control, whereas alcaftadine 0.25% provides the highest likelihood of hyperemia resolution. Clinical management should adopt a personalized step-ladder approach: utilizing potent once-daily dual-acting agents (0.77% olopatadine or 0.25% alcaftadine) as first-line therapy for acute or seasonal exposure. Short-term topical corticosteroids (such as 0.2% loteprednol etabonate) should be strictly reserved for severe natural exposure non-responsive to dual-acting agents, with mandatory intraocular pressure monitoring, before transitioning back to dual-acting maintenance.

PMID 43042078
阅读全文 →
PubMedDalton transactions (Cambridge, England : 2003)2026-11-17

Bismuth phosphanides Bi(PR2)3 react with chalcogens and P4: oxidation vs. transfer of the phosphanyl (PR2) unit.

Reith Sascha S, Jakobi Felix F, Dunaj Tobias T, Lichtenberg Crispin C

Simple, homoleptic bismuth phosphanides Bi(PR2)3 (R2 = tBuCy, tBu2) have recently been introduced to the literature. With the aim of mapping the reactivity profiles of these interpnictogen compounds, reactions with elemental chalcogens (S8, Segrey, Te) and white phosphorus (P4) have been investigated. In these reactions, oxidation of the P atoms in the coordination sphere of bismuth is shown to compete with phosphanyl (PR2) transfer from bismuth to the group 15/16 element. Phosphanyl transfer to P4 grants selective bottom-up access to the complex structural motif (PPR2)4 in a single step. Analytical methods applied in this work include (heteronuclear) NMR spectroscopy, high-resolution mass spectrometry, and single-crystal X-ray analyses.

PMID 43041163
阅读全文 →
PubMedHealth science reports2026-11-17

Oral Health Knowledge, Practice, and Oral Health Status among Garment Employees of Bangladesh: A Cross-Sectional Study.

Razon Arafat Hassan AH, Biswas Dibakar D, Hossain Farhad F, Karim Sakiratul S et al.

Oral health remain an overlooked component of workers' well-being in low-income settings, particularly in labour-intensive industries such as Bangladesh's ready-made garment (RMG) sector. So, the major aim of this study was to assess the oral health knowledge, practices, and self-reported oral health status among Bangladeshi garment employees. A cross-sectional survey was conducted among 502 garment workers from Gazipur district between May and December 2024. Data on oral health knowledge, hygiene practices, and self-reported symptoms were collected using a validated questionnaire. Descriptive statistics, chi-square tests, and logistic regression analyses were performed. Although 76.5% (384/502) of participants demonstrated good oral health knowledge, 29.3% (147/502) reported a need for dental care. Healthy oral hygiene practices were highly prevalent (493/502, 98.2%), yet knowledge, age, marital status, and education were significantly associated with oral health outcomes (p < 0.05). Workers experiencing dental pain within the previous 12 months were 58.9 times more likely to seek treatment (AOR = 58.89; 95% CI: 32.90-105.41). This study highlights a critical gap between knowledge and actual oral health needs among garment workers. The findings underscore the need for workplace-based oral health education, affordable dental services, and integration of oral care into occupational health policies.

PMID 43041832
阅读全文 →
PubMedFood & function2026-11-17

Tailoring foods to enhance protein intake in older adults: effects on oral processing and oral comfort perception.

Houinsou-Houssou Bérénice B, Septier Chantal C, Sounouvou Cindy C, Gwala Shannon S et al.

The development of familiar, protein-enriched foods represents a promising strategy to improve protein intake in older adults without requiring major dietary changes. However, foods designed to meet older adults' nutritional needs are not necessarily perceived as comfortable to consume. This study investigated oral comfort perceptions in 80 community-dwelling adults aged over 65 years while consuming three nutritionally adapted food products and their respective controls: a whey-protein-enriched dairy dessert (dulce de leche) containing 20% protein compared to 7% for the control, a chickpea-based breakfast cereal enriched with maca (0.03% in the shell) and olive leaf extract (0.015% in the filling), and a tenderized beefsteak treated by blade tenderization and brine injection. Oral comfort was assessed alongside unstimulated and stimulated salivary flow, saliva viscosity, bolus mechanical properties, and oral processing behavior. Overall, enrichment and processing strategies were effective, with modified products perceived as equally or more comfortable than their reference counterparts. Across the three food matrices, oral comfort was associated with bolus properties. Whey protein enrichment improved oral comfort in dulce de leche, primarily through favorable textural modifications without compromising flavor. In contrast, only minor sensory differences were observed between cereal formulations, suggesting limited effects of maca and olive leaf extract on oral comfort perception. Finally, beefsteak tenderization significantly enhanced oral comfort through textural modifications that facilitated bolus formation and notably reduced chewing effort. The effects of nutritional and technological reformulation on oral comfort depended on the food matrix. These findings highlight the importance of considering food texture, oral processing and bolus properties alongside nutritional composition when designing foods for older adults.

PMID 43043092
阅读全文 →
PubMedGerodontology2026-11-17

Oral Health in Long Term Residential Care in Ireland-A Qualitative Study With Healthcare Staff.

Curtin Claire C, Burke Francis M FM, McKenna Gerald G, Hayes Martina M

This study aimed to explore staff perceptions and experiences of oral care provision in a publicly funded long-stay ward of a community hospital in Ireland. Oral health is a critical component of overall health and quality of life in older adults, particularly those in long-term residential care who are at higher risk of oral disease due to age-related changes, multimorbidity, and reliance on caregivers. Cognitive impairment further complicates care provision, making the knowledge and practices of nursing staff and healthcare assistants essential. A qualitative study design was employed using semi-structured interviews, underpinned by reflexive thematic analysis. Participants included nursing staff and healthcare assistants recruited through convenience sampling from long-stay wards in a community hospital. Twelve semi-structured interviews were conducted on the long-stay wards of the community hospital during August 2025. Participants included nurse managers, senior nurses, staff nurses, and healthcare assistants. Following reflexive thematic analysis, four major themes, each with associated subthemes, emerged from the data: (1) Perceived Importance of Oral Care as Part of Overall Personal Care for Residents; (2) Nurses and Healthcare Professionals as Providers, Supporters, and Promoters of Independence in Oral Care; (3) Reliance on Informal Learning Methods for Oral Care Skill Acquisition; and (4) The Importance of Collaboration with Other Healthcare Professionals and Services for Oral Health Support. Despite positive attitudes towards oral care, systemic and organisational challenges hinder its consistent delivery. Addressing these barriers through formal training, interdisciplinary collaboration, and organisational support may improve oral health outcomes. Further research should examine the impact of targeted interventions and national guidelines on oral care practices in long-term care settings.

PMID 43041127
阅读全文 →
PubMedInternational journal of pharmaceutics: X2026-11-17

Polydopamine-coated liposomes for oral delivery of tirzepatide: Overcoming gastrointestinal barriers to improve therapeutic efficacy.

Wan Xian X, Kong Weibo W, Gao Zihan Z, Pan Yafeng Y et al.

Tirzepatide (TZP), the first dual GIP/GLP-1 receptor agonist, offers substantial therapeutic benefits for type 2 diabetes mellitus (T2DM) but remains confined to subcutaneous injection. While oral delivery of peptide therapeutics improves patient compliance, it is severely hampered by enzymatic degradation and mucosal barriers in the gastrointestinal tract. Liposomes, as biocompatible nanocarriers, can protect encapsulated drugs, enhance intestinal stability, and enable controlled release. Herein, TZP-loaded liposomes (TZP-Lip) were prepared via reverse-phase evaporation and further coated with polydopamine (PDA) to obtain TZP-Lip@PDA for enhanced oral delivery. TZP-Lip@PDA exhibited an encapsulation efficiency of 95.02 ± 1.14%, a particle size of 145.9 ± 1.49 nm, and preservation of the secondary structure of TZP. The PDA coating functioned as a physical diffusion barrier that conferred sustained-release behavior in simulated gastrointestinal fluids, while enhancing mucus penetration and promoting cellular uptake in Caco-2 cells. Pharmacokinetic studies showed that oral TZP-Lip@PDA achieved measurable plasma exposure, whereas oral free TZP remained below the lower limit of quantification (LLOQ, 5 ng/mL). Despite a tenfold higher dose (8.8 vs 0.88 mg/kg), oral TZP-Lip@PDA achieved a Cmax approximately 50% of that observed after subcutaneous administration of free TZP, within the 12-h sampling window, indicating substantial progress but also the remaining quantitative gap between the two routes. In T2DM rats, oral TZP-Lip@PDA (8.8 mg/kg) significantly enhanced the integrated hypoglycemic response during the 12-h observation period compared with oral free TZP and TZP-Lip. In summary, TZP-Lip@PDA enhances the oral delivery of TZP by sustaining drug release, enhancing mucus penetration and promoting cellular uptake, which offers a potential strategy for peptide and protein oral delivery.

PMID 43041286
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多epinastine